Charcot Fund: fundamental research

Laureates 2023
Development of a CD19 CAR T cell therapy for multiple sclerosis
Dr Barbara Willekens and Prof. Nathalie Cools
UAntwerpen
€72,400
1 year
2 years

There is a clear unmet need for innovative treatments that can suppress ongoing inflammatory disease activity in treatment refractory relapsing-remitting MS (RRMS) patients. The grant of the Belgian Charcot Foundation enables us to start developing CD19 CAR T cells for the use in MS and related autoimmune diseases that are driven by pathogenic B cells. While the current project is focused on laboratory research, we are committed to paving the road towards a first-in-man clinical trial in the future.
Stay informed
Receive all the information related to research and news from the Charcot Foundation directly in your inbox.
By clicking on “I register”, you agree to our Privacy policy
